Glofitamab, sold under the brand name Columvi, is a bispecific monoclonal antibody used for the treatment of large B-cell lymphoma. It is a bispecific...
15 KB (1,043 words) - 23:43, 23 March 2024
Bi-specific T-cell engager (section Glofitamab)
Bi-specific T-cell engagers (BiTEs) are a class of artificial bispecific monoclonal antibodies that are investigated for use as anti-cancer drugs. They...
9 KB (1,471 words) - 05:56, 8 August 2024
(Bevacizumab) Leukemia/lymphoma lymphoid: CD3 (Glofitamab, Elranatamab, Mosunetuzumab), CD20 (Glofitamab Ibritumomab Mosunetuzumab Obinutuzumab Ofatumumab...
12 KB (760 words) - 03:40, 23 July 2024
(Bevacizumab) Leukemia/lymphoma lymphoid: CD3 (Glofitamab, Elranatamab, Mosunetuzumab), CD20 (Glofitamab Ibritumomab Mosunetuzumab Obinutuzumab Ofatumumab...
12 KB (758 words) - 23:46, 14 March 2024
adult patients with relapsed or refractory DLBCL after systemic therapy. Glofitamab (Columvi) is a bispecific monoclonal antibody that was approved for medical...
69 KB (8,143 words) - 18:36, 22 January 2024
carcinoma Glembatumumab vedotin mab human GPNMB melanoma, breast cancer Glofitamab Columvi BsAb humanized CD20, CD3 Y diffuse large B-cell lymphoma Golimumab...
135 KB (4,054 words) - 22:35, 2 July 2024
Mosunetuzumab L01FX26 Mirvetuximab soravtansine L01FX27 Epcoritamab L01FX28 Glofitamab L01FX29 Talquetamab L01FY01 Pertuzumab and trastuzumab L01FY02 Nivolumab...
12 KB (877 words) - 15:36, 25 January 2024
amivantamab, tebentafusp, faricimab, teclistamab, mosunetuzumab, epcoritamab, glofitamab. Among the bsAb programs currently under development, the combination...
29 KB (3,349 words) - 19:04, 30 July 2024
(INN) glisoxepide (INN) globin zinc insulin injection (INN) Glofil-125 glofitamab (INN) gloxazone (INN) gloximonam (INN) Glucagen glucagon (INN) glucalox...
14 KB (644 words) - 04:49, 5 August 2024
Etaracizumab§ Farletuzumab§ Ficlatuzumab§ Flotetuzumab§ Gemtuzumab ozogamicin Glofitamab Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§...
3 KB (129 words) - 01:04, 19 July 2023
Etaracizumab§ Farletuzumab§ Ficlatuzumab§ Flotetuzumab§ Gemtuzumab ozogamicin Glofitamab Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§...
5 KB (368 words) - 23:51, 17 July 2024
Etaracizumab§ Farletuzumab§ Ficlatuzumab§ Flotetuzumab§ Gemtuzumab ozogamicin Glofitamab Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§...
4 KB (241 words) - 13:42, 14 July 2024